Clinical Dialogue: New Opportunities in the Treatment of COVID-19

At the onset of the pandemic, patients with suspected COVID-19 infection and with typical symptoms were treated as having COVID-19 even in the absence of positive test results. However, at this point, given the availability of testing in the United States, the Centers for Disease Control (CDC) and Infectious Diseases Society of America (IDSA) recommend SARS-CoV-2 testing where available. Current treatments for the outpatient treatment COVID-19 have garnered much attention in the medical community and the broader media. Many treatments are not supported by available evidence or carry a risk profile that may not warrant their use. Given the difficulty in outpatient administration of IV or subcutaneous monoclonal antibodies, researchers have been working towards the oral treatment of COVID-19. Several candidates are in late-stage clinical trials, with some emerging clinical data. As such, providers require an educational program that broadly encompasses the testing and treatment of COVID-19, so they will be able to properly counsel patients.

Learning Objectives

At the conclusion of this activity, the PA should be better able to:
 
  • Apply understanding of COVID-19 testing methods to patient counseling and treatment choices
  • Incorporate knowledge of currently authorized/approved and recommended COVID-19 treatments to the outpatient management of patients with COVID-19
  • Use knowledge of emerging COVID-19 treatments to better counsel and manage affected patients

Acknowledgement of Commercial Support


Supported by an independent educational grant from Merck Sharp & Dohme Corp.